Domov › Rakovina prsníka › New Jersey › Newark
Klinické štúdie Rakovina prsníka v meste Newark, NJ
18 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v meste Newark a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Prebieha náborFáza 3
- Summit Health, Florham Park · 12 míľ odtiaľ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Morristown Medical Center, Morristown · 17 míľ odtiaľ
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Prebieha náborFáza 2
- Medical Oncology Hematology Associates, Newark
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Prebieha náborFáza 1/2
- Summit Medical Group, Florham Park · 12 míľ odtiaľ
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Prebieha náborFáza 3
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · 9 míľ odtiaľ
- Summit Medical Group PA, Florham Park · 12 míľ odtiaľ
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Prebieha náborFáza 3
- Summit Medical Group, Florham Park · 12 míľ odtiaľ
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Prebieha náborFáza 3
- Summit Medical Group, Florham Park · 12 míľ odtiaľ
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Prebieha náborObservačná štúdia
- Summit Medical Group, Florham Park · 12 míľ odtiaľ
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Prebieha náborFáza 3
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · 9 míľ odtiaľ
- Morristown Medical Center, Morristown · 17 míľ odtiaľ
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Prebieha náborFáza 2
- GSK Investigational Site, Morristown · 17 míľ odtiaľ
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Prebieha náborFáza 3
- Morristown Medical Center, Morristown · 17 míľ odtiaľ
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Prebieha nábor
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Prebieha náborObservačná štúdia
- Morristown Medical Center, Morristown · 17 míľ odtiaľ
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Prebieha nábor
- Summit Health, Florham Park · 12 míľ odtiaľ
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
Prebieha náborFáza 1
- RWJBarnabas Health Clara Maas Medical Center, Belleville · 4 míľ odtiaľ
- Cooperman Barnabas Medical Center, Livingston · 9 míľ odtiaľ
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Prebieha náborFáza 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
Prebieha náborFáza 4
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- a 2 ďalších
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Prebieha náborFáza 3
- Morristown Medical Center, Morristown · 17 míľ odtiaľ
Štúdie Rakovina prsníka v iných mestách
- New York City, NY136 štúdií
- Houston, TX126 štúdií
- Boston, MA112 štúdií
- Nashville, TN81 štúdií
- Los Angeles, CA73 štúdií
- Edison, NJ68 štúdií
- St. Louis, MO64 štúdií
- Queens, NY64 štúdií
- Durham, NC64 štúdií
- Chicago, IL59 štúdií
- Philadelphia, PA56 štúdií
- Dallas, TX55 štúdií
Iné štúdie v Newark
- Poranenia miechy13 štúdií
- Nemalobunkový karcinóm pľúc13 štúdií
- Akútna myeloidná leukémia12 štúdií
- Srdcové zlyhanie10 štúdií
- Metastatická rakovina10 štúdií
- Kardiovaskulárne ochorenia9 štúdií
- Rakovina pankreasu9 štúdií
- Melanóm8 štúdií
- Rakovina (všetky typy)7 štúdií
- Rakovina pľúc7 štúdií
- Crohnova choroba7 štúdií
- Stenóza aortálnej chlopne6 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.